S-1/A: MSP Recovery Files Amendment No. 3 to Form S-1, Registers Resale of 4.1 Million Shares
S-1/A Filing
MSP Recovery aims to register the resale of over 4.1 million shares of Class A common stock by selling securityholders, including shares from a warrant agreement.
Summary
- MSP Recovery has filed an amendment to its Form S-1 registration statement.
- The filing concerns the potential resale of up to 4,136,441 shares of Class A common stock.
- This includes 2,666,667 shares issuable upon exercise of a warrant held by Brickell Key Investments LP.
- The exercise price of the warrant is $0.0025 per share, resulting in nominal proceeds to the company if exercised.
- The company will not receive any proceeds from the sale of these shares by the selling securityholders.
- The company's Class A Common Stock is traded on the Nasdaq under the symbol LIFW, with a last reported sale price of $0.7700 on February 8, 2024.
- The document highlights various recent developments, including compliance with Nasdaq listing requirements, Hazel transactions, Virage amendments, and a Yorkville facility.
- The company is also subject to ongoing investigations by the SEC and the U.S. Attorneys Office.
Sentiment
Score: 4
Explanation: The document contains a mix of positive and negative elements. While the company has addressed Nasdaq compliance issues and secured some funding, there are significant concerns about liquidity, debt obligations, and ongoing investigations, leading to a cautious sentiment.
Positives
- The company has regained compliance with Nasdaq listing rules.
- The company has secured funding from Hazel Partners Holdings LLC.
- The company has entered into a Standby Equity Purchase Agreement with Yorkville for up to $250 million.
Negatives
- The company will not receive any proceeds from the sale of shares by the selling securityholders.
- The company has a $5.0 million receivable outstanding from Cano Health, but has established a reserve due to concerns about Cano's ability to continue as a going concern.
- The company is subject to ongoing investigations by the SEC and the U.S. Attorneys Office.
- The company does not currently have sufficient available liquidity to satisfy obligations under the Virage MTA and Nomura Promissory Note.
Risks
- Investing in the company's securities involves a high degree of risk.
- The company has a history of losses and no substantial revenue to date.
- Litigation outcomes are inherently risky and can adversely affect the company's recovery efforts.
- The company's fee sharing arrangement with the Law Firm materially reduces recoveries.
- The company is subject to extensive government regulation.
- The company has a substantial amount of indebtedness and payment obligations.
- The market price of the company's Class A Common Stock may be significantly volatile.
- The company may be required to take write-downs or write-offs, restructuring, and impairment or other charges that could have a significant negative effect on our financial condition and our stock price.
- The company may be unable to obtain additional financing to fund the operations and growth of the Company.
- The company is controlled by the Members, including John H. Ruiz and Frank C. Quesada, whose interests may conflict with our interests and the interests of other stockholders.
Future Outlook
The company intends to rely on its primary sources of cash to continue to support its operations and plans to work with lenders to restructure indebtedness and payment obligations.
Industry Context
The document relates to the healthcare recoveries and data analytics industry, specifically focusing on Medicare, Medicaid, and commercial insurance spaces. The company aims to disrupt the healthcare reimbursement system by identifying and recovering improper payments.
Comparison to Industry Standards
- The document does not provide specific comparisons to industry standards or competitors.
- It mentions that the company differs from competitors by receiving recovery rights through irrevocable assignments of Claims.
- It also states that it would take a long time for any competitor to amass the portfolio of Claims rights currently owned by the company.
Legal Proceedings
- The Securities and Exchange Commission (the SEC) initiated an investigation of the Company.
- The Company received a subpoena from the U.S. Attorneys Office in connection with a grand jury investigation in the U.S. District Court for the Southern District of Florida.
- The Company sued Cano in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for declaratory relief and anticipatory breach of the Cano Agreements.
- Cano sued the Company in the same court, alleging fraud in the inducement, breach of contract, tortious interference, and unjust enrichment relating to the Cano Agreements.
- On January 4, 2024, Cano sued Simply Healthcare Plans, Inc. (Simply) and the Company and affiliated entities seeking a declaratory judgment to determine whether the Cano Purchase Agreement should be rescinded, and whether Cano or the Company have standing to recover on claims assigned to the Company against Simply under the Cano Purchase Agreement.
Related Party Transactions
- The company has entered into a Legal Services Agreement with La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC.
- The company has received aviation services from MSP Recovery Aviation, LLC.
- The company has funds held for other entities.
- The company has a Virage Swap.
Stakeholder Impact
- Shareholders will experience dilution as a consequence of further issuances of the company's stock.
- The market price of the company's Class A Common Stock may be significantly volatile.
- The company's stockholders may be held liable for claims by third parties against the Company to the extent of distributions received by them.
Next Steps
- The company intends to fully cooperate with the SEC in responding to the subpoenas.
- The company plans to work with the lenders to restructure the indebtedness and payment obligations.
- The company intends to vigorously assert its position in all Cano related litigation.
Key Dates
| Date | Description |
|---|---|
| August 13, 2020 | Date of the Existing Warrant Agreement. |
| July 11, 2021 | Date of the Membership Interest Purchase Agreement (MIPA). |
| May 23, 2022 | Closing date of the Business Combination. |
| September 30, 2022 | Date of the CPIA Warrant agreement. |
| October 13, 2023 | Effective date of the 1-for-25 reverse stock split. |
| February 8, 2024 | Last reported sale price of Class A Common Stock on Nasdaq was $0.7700 per share. |
| February 9, 2024 | Date of the prospectus. |
Keywords
Class A Common Stock, Registration Statement, Selling Securityholders, Warrants, MSP Recovery, Resale, Securities, CPIA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.